ANAB vs CB · rev $91.3M vs P/E 14, rev $59.40B
AnaptysBio Inc (ANAB) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ANAB currently screens at market cap $1.62B. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ANAB and CB stock pages for the full models.
Not investment advice.